{"id":"https://openalex.org/W2327490802","doi":"https://doi.org/10.1089/088922201300343681","title":"Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody Responses","display_name":"Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody Responses","alternate_titles":[],"publication_year":2001,"publication_date":"2001-07-20","ids":{"openalex":"https://openalex.org/W2327490802","doi":"https://doi.org/10.1089/088922201300343681","mag":"2327490802","pmid":"https://pubmed.ncbi.nlm.nih.gov/11485617"},"language":"en","primary_location":{"id":"doi:10.1089/088922201300343681","doi":"https://doi.org/10.1089/088922201300343681","is_oa":false,"landing_page_url":"https://doi.org/10.1089/088922201300343681","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2327490802"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018591867","display_name":"Daan W. Notermans","orcid":"https://orcid.org/0000-0002-9494-0989","observed_orcids":["https://orcid.org/0000-0002-9494-0989"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Daan W. Notermans","raw_affiliation_strings":["Division of Infectious Diseases, Tropical Medicine, and AIDS and National AIDS Therapy Evaluation Center (NATEC), AMC, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Tropical Medicine, and AIDS and National AIDS Therapy Evaluation Center (NATEC), AMC, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074789038","display_name":"Jacques J. de Jong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. Jacques de Jong","raw_affiliation_strings":["Organon Teknika, Boxtel, 5281 RM, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organon Teknika, Boxtel, 5281 RM, The Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109872740","display_name":"Jaap Goudsmit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jaap Goudsmit","raw_affiliation_strings":["Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040038561","display_name":"Margreet E. Bakker","orcid":"https://orcid.org/0000-0002-3803-3380","observed_orcids":["https://orcid.org/0000-0002-3803-3380"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Margreet Bakker","raw_affiliation_strings":["Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108228237","display_name":"Marijke T.L. Roos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marijke T.L. Roos","raw_affiliation_strings":["Department of Clinical Viro-Immunology, CLB, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Viro-Immunology, CLB, 1066 CX, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013153241","display_name":"Liekle J. Nijholt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Liekle Nijholt","raw_affiliation_strings":["Organon Teknika, Boxtel, 5281 RM, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organon Teknika, Boxtel, 5281 RM, The Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020402951","display_name":"Jeanne Cremers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jeanne Cremers","raw_affiliation_strings":["Organon Teknika, Boxtel, 5281 RM, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organon Teknika, Boxtel, 5281 RM, The Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057702781","display_name":"Jan-Albert Hellings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan-Albert Hellings","raw_affiliation_strings":["Organon Teknika, Boxtel, 5281 RM, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organon Teknika, Boxtel, 5281 RM, The Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103637692","display_name":"Sven A. Danner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sven A. Danner","raw_affiliation_strings":["Division of Infectious Diseases, Tropical Medicine, and AIDS and National AIDS Therapy Evaluation Center (NATEC), AMC, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Tropical Medicine, and AIDS and National AIDS Therapy Evaluation Center (NATEC), AMC, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109112003","display_name":"Anthony de Ronde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anthony de Ronde","raw_affiliation_strings":["Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Retrovirology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8249,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.83733999,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"11","first_page":"1003","last_page":"1008"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.699999988079071},{"id":"https://openalex.org/keywords/hypergammaglobulinemia","display_name":"hypergammaglobulinemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/total-igg","display_name":"total IgG","score":0.8489999771118164},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.8790000081062317},{"id":"https://openalex.org/keywords/p24","display_name":"p24","score":0.9929999709129333},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.8360000252723694},{"id":"https://openalex.org/keywords/t-cell-immunodeficiency","display_name":"T cell deficiency","score":0.6610000133514404},{"id":"https://openalex.org/keywords/structured-treatment-interruption","display_name":"structured treatment interruption","score":0.6859999895095825},{"id":"https://openalex.org/keywords/therapeutic-vaccination","display_name":"therapeutic vaccination","score":0.902999997138977}],"concepts":[{"id":"https://openalex.org/C2780514984","wikidata":"https://www.wikidata.org/wiki/Q17146775","display_name":"Hypergammaglobulinemia","level":3,"score":0.9370191693305969},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6773085594177246},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6139740943908691},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5536563396453857},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5205560326576233},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.4687032401561737},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.44860509037971497},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4113249182701111},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38743454217910767},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.33387473225593567},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.333281934261322}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006942","descriptor_name":"Hypergammaglobulinemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016655","descriptor_name":"HIV Core Protein p24","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016655","descriptor_name":"HIV Core Protein p24","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1089/088922201300343681","doi":"https://doi.org/10.1089/088922201300343681","is_oa":false,"landing_page_url":"https://doi.org/10.1089/088922201300343681","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},{"id":"pmid:11485617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11485617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and human retroviruses","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/09466c5f-d62c-4d49-8261-336ff1f98763","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/09466c5f-d62c-4d49-8261-336ff1f98763","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Notermans, D W, de Jong, J J, Goudsmit, J, Bakker, M, Roos, M T, Nijholt, L, Cremers, J, Hellings, J A, Danner, S A & de Ronde, A 2001, 'Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses', AIDS research and human retroviruses, vol. 17, no. 11, pp. 1003-1008. https://doi.org/10.1089/088922201300343681","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/95eee10b-2a8a-4072-9a85-4c3daf737e08","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/95eee10b-2a8a-4072-9a85-4c3daf737e08","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Notermans, D W, De Jong, J J, Goudsmit, J, Bakker, M, Roos, M T L, Nijholt, L, Cremers, J, Hellings, J A, Danner, S A & De Ronde, A 2001, 'Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in hiv type 1-specific antibody responses', AIDS Research and Human Retroviruses, vol. 17, no. 11, pp. 1003-1008. https://doi.org/10.1089/088922201300343681","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/0a30b859-2099-48db-acd4-0632c9b4df0a","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/potent-antiretroviral-therapy-initiates-normalization-of-hypergammaglobulinemia-and-a-decline-in-hiv-type-1specific-antibody-responses(0a30b859-2099-48db-acd4-0632c9b4df0a).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS research and human retroviruses, 17(11), 1003 - 1008. Mary Ann Liebert Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/95eee10b-2a8a-4072-9a85-4c3daf737e08","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/95eee10b-2a8a-4072-9a85-4c3daf737e08","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Research and Human Retroviruses, 17(11), 1003 - 1008. Mary Ann Liebert Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1574561647","https://openalex.org/W1753511464","https://openalex.org/W1969491032","https://openalex.org/W1975403569","https://openalex.org/W1977489960","https://openalex.org/W1977900942","https://openalex.org/W1982448824","https://openalex.org/W1987039284","https://openalex.org/W1990768351","https://openalex.org/W1996609637","https://openalex.org/W1999347854","https://openalex.org/W2015693740","https://openalex.org/W2042411177","https://openalex.org/W2053349531","https://openalex.org/W2054697232","https://openalex.org/W2064140408","https://openalex.org/W2072053153","https://openalex.org/W2072856319","https://openalex.org/W2082210762","https://openalex.org/W2104978149","https://openalex.org/W2114654929","https://openalex.org/W2116983636","https://openalex.org/W2119063189","https://openalex.org/W2129114331","https://openalex.org/W2144010988","https://openalex.org/W2147004263","https://openalex.org/W2147071499","https://openalex.org/W2152464646","https://openalex.org/W2154465636","https://openalex.org/W2154987377","https://openalex.org/W2156819923","https://openalex.org/W2158035002","https://openalex.org/W2159669315","https://openalex.org/W2163345314","https://openalex.org/W2313903145","https://openalex.org/W2319153630","https://openalex.org/W2334955829"],"related_works":["https://openalex.org/W2147071499","https://openalex.org/W2151923950","https://openalex.org/W2169749417","https://openalex.org/W2046135856","https://openalex.org/W2316742204","https://openalex.org/W3003228485","https://openalex.org/W2317107786","https://openalex.org/W2072856319","https://openalex.org/W1999347854","https://openalex.org/W2155647946"],"abstract_inverted_index":{"Next":[0],"to":[1,52,167],"a":[2,70],"profound":[3],"T":[4,20],"cell":[5,21,38],"immunodeficiency,":[6],"HIV-1":[7],"infection":[8],"induces":[9],"activation":[10],"and":[11,57,59,76,106,127],"dysfunction":[12],"of":[13,45,84,131,156],"B":[14,37],"cells,":[15],"resulting":[16],"in":[17,102,112,122,136],"hypergammaglobulinemia.":[18],"Whereas":[19],"immune":[22,39,150],"reconstitution":[23],"with":[24,78,159],"potent":[25,46,142],"antiretroviral":[26,47,143],"therapy":[27,48,114,138,144,160],"has":[28],"been":[29],"extensively":[30],"documented,":[31],"limited":[32],"data":[33],"are":[34],"available":[35],"on":[36,49,60],"reconstitution.":[40],"We":[41],"studied":[42],"the":[43,53,88,92,103,113,123,129,132,137,145,172],"effect":[44],"antibody":[50,119],"titers":[51,120],"viral":[54],"proteins":[55],"gp120":[56],"p24":[58],"total":[61,94],"IgG":[62,95],"concentrations.":[63],"Three":[64],"retrospectively":[65],"chosen":[66],"groups":[67],"were":[68,152],"studied:":[69],"successfully":[71,89,124],"treated":[72,90,125],"group,":[73,91],"untreated":[74,104],"controls,":[75],"subjects":[77],"virological":[79],"failure":[80,115,139],"after":[81,108],"several":[82],"months":[83],"successful":[85],"therapy.":[86],"In":[87],"median":[93],"concentrations":[96],"normalized,":[97],"whereas":[98,148],"they":[99],"remained":[100],"elevated":[101],"group":[105,126],"rebounded":[107],"an":[109],"initial":[110],"decline":[111],"group.":[116,140],"The":[117,154],"HIV-1-specific":[118,149],"declined":[121],"followed":[128],"rebound":[130],"HIV":[133],"RNA":[134],"levels":[135],"With":[141],"hypergammaglobulinemia":[146],"normalized":[147],"responses":[151],"weakened.":[153],"weakening":[155],"antiviral":[157],"immunity":[158],"may":[161],"be":[162],"relevant":[163],"for":[164],"current":[165],"attempts":[166],"gain":[168],"immunological":[169],"control":[170],"over":[171],"virus":[173],"through":[174],"structured":[175],"treatment":[176],"interruptions":[177],"or":[178],"therapeutic":[179],"vaccinations.":[180]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2327490802","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
